Issue 005 | U.S. Pilot | US

SNSE

Sensei Biotherapeutics, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-15 Filing currency: USD

Open Filing Back to Register Report a correction

Internal NCAV Discount 83.6%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets: 204,232,000USD
Total Liabilities: 14,191,000USD
NCAV: 190,041,000USD
Cash: 152,325,000USD
NCAV per share: 141.79USD/share
Evidence: 7 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated: 12
Triggered: 2
Unavailable: 7

Requires inspection Negative OCF -10,733,000

Latest: -10,733,0002026-03-31
Comparison: n/a
Change: n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-225333

Supporting observation Current Ratio > 1.5 14.39

Latest: 14.392026-03-31
Comparison: 1.5
Change: n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-225333

7 unavailable checks — inspect missing inputs

High Debt (short-term debt + long-term debt) / ordinary equity >= 50%

Low Debt (short-term debt + long-term debt) / ordinary equity < 20%

Material 1Y Share Increase 1Y share change >= +2% using the same share-count source

NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive

No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source

Non-Positive Equity ordinary shareholders equity <= 0

Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis Normalized to latest verified split basis As reported in each filing

Metric	2026-03-31 10-Q Open filing	2025-12-31 10-K Open filing	2025-09-30 10-Q Open filing	2025-06-30 10-Q Open filing	2025-03-31 10-Q Open filing	2024-12-31 10-K Open filing	2024-09-30 10-Q Open filing	2024-06-30 10-Q Open filing	2024-03-31 10-Q Open filing	2023-12-31 10-K Open filing	2023-09-30 10-Q Open filing	2023-06-30 10-Q Open filing	2023-03-31 10-Q Open filing	2022-12-31 10-K Open filing	2022-09-30 10-Q Open filing	2022-06-30 10-Q Open filing	2022-03-31 10-Q Open filing	2021-12-31 10-K Open filing	2021-09-30 10-Q Open filing	2021-06-30 10-Q Open filing	2020-12-31 10-K Open filing
Period-end Shares Outstanding	1,340,3331,340,333	1,261,6851,261,685	n/an/a	n/an/a	1,260,40325,208,068	1,259,02925,180,583	1,257,56925,151,379	1,256,21725,124,333	1,253,69825,073,958	1,251,50925,030,188	1,249,82624,996,517	1,329,19126,583,819	1,548,56730,971,341	1,538,20830,764,160	1,536,04630,720,921	1,536,04630,720,921	1,534,14130,682,813	1,530,45130,609,029	1,529,42530,588,495	1,529,42530,588,495	n/an/a
Weighted-average Basic Shares	1,295,0521,295,052	1,260,7721,260,772	n/an/a	n/an/a	n/an/a	1,397,64327,952,857	1,447,14028,942,803	1,534,27830,685,561	1,543,30430,866,087	1,397,64327,952,857	1,275,70625,514,115	1,525,35130,507,018	n/an/a	1,385,53427,710,686	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Weighted-average Diluted Shares	1,295,0521,295,052	1,255,7761,255,776	1,261,2901,261,290	1,260,8671,260,867	1,259,61825,192,363	1,255,86225,117,238	1,257,40025,147,999	1,255,22225,104,439	1,252,45625,049,111	1,535,16530,703,295	1,275,70625,514,115	1,525,35130,507,018	1,543,30430,866,087	1,535,16530,703,295	1,536,01530,720,291	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Basic EPS	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Diluted EPS	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Basic-to-Diluted Share Difference	0.0%	-0.4%	Insufficient evidence	Insufficient evidence	Insufficient evidence	-10.1%	-13.1%	-18.2%	-18.8%	9.8%	0.0%	0.0%	Insufficient evidence	10.8%	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence
Net Share Count Change	6.2%	Insufficient evidence	Insufficient evidence	Insufficient evidence	0.1%	0.1%	0.1%	0.2%	0.2%	0.1%	-6.0%	-14.2%	0.7%	0.1%	0.0%	0.1%	0.2%	0.1%	0.0%	Insufficient evidence	Insufficient evidence
Ownership Claim Change	-5.9%	Insufficient evidence	Insufficient evidence	Insufficient evidence	-0.1%	-0.1%	-0.1%	-0.2%	-0.2%	-0.1%	6.4%	16.5%	-0.7%	-0.1%	0.0%	-0.1%	-0.2%	-0.1%	0.0%	Insufficient evidence	Insufficient evidence

Verified split events: reverse 48.0 on 2021-01-29; reverse 20.0 on 2025-06-16

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric	2025-12-31 10-K USD	2024-12-31 10-K USD	2023-12-31 10-K USD	2022-12-31 10-K USD	2021-12-31 10-K USD	2020-12-31 10-K USD	2020-12-31 10-K USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-22,288,000	-32,614,000	-37,064,000	-50,188,000	-37,482,000	-19,451,000	-19,451,000
Net Income	-21,085,000	-30,157,000	-34,101,000	-48,588,000	-36,794,000	-20,100,000	-20,100,000
Cash From Operations	-20,453,000	-24,670,000	-32,023,000	-39,026,000	-30,259,000	-17,705,000	-17,705,000
Capex	-16,000	-146,000	-180,000	-321,000	-2,026,000	-1,206,000	-1,206,000
Free Cash Flow	-20,469,000	-24,816,000	-32,203,000	-39,347,000	-32,285,000	-18,911,000	-18,911,000
Cash And Equivalents	8,668,000	9,994,000	13,011,000	17,795,000	7,159,000	16,596,000	16,596,000
Accounts Receivable	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	21,507,000	41,929,000	67,250,000	108,589,000	148,542,000	20,076,000	20,076,000
Total Assets	22,902,000	45,361,000	74,374,000	118,375,000	153,225,000	21,428,000	21,428,000
Total Current Liabilities	4,251,000	5,448,000	5,643,000	9,066,000	4,889,000	4,830,000	4,830,000
Total Liabilities	4,310,000	6,975,000	9,479,000	14,968,000	6,712,000	5,535,000	5,535,000
Shareholders Equity	18,592,000	38,386,000	64,895,000	103,407,000	146,513,000	-56,443,000	-56,443,000
Shares Outstanding	1,261,685	25,180,583	25,030,188	30,764,160	30,609,029	1,875,422	1,875,422
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	1,260,772	25,117,238	27,952,857	30,703,295	27,710,686	n/a	1,612,140
Weighted Avg Shares Basic	1,260,772	25,117,238	27,952,857	30,703,295	27,710,686	n/a	1,612,140
Net Share Count Change (Normalized)	Insufficient evidence	0.1%	0.1%	0.1%	0.1%	Insufficient evidence	Insufficient evidence
Ownership Claim Change (Normalized)	Insufficient evidence	-0.1%	-0.1%	-0.1%	-0.1%	Insufficient evidence	Insufficient evidence

Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric	2026-03-31 10-Q USD	2025-12-31 10-K USD	2025-09-30 10-Q USD	2025-06-30 10-Q USD	2025-03-31 10-Q USD	2024-12-31 10-K USD	2024-09-30 10-Q USD	2024-06-30 10-Q USD	2024-03-31 10-Q USD	2023-12-31 10-K USD	2023-09-30 10-Q USD	2023-06-30 10-Q USD	2023-03-31 10-Q USD	2022-12-31 10-K USD	2022-09-30 10-Q USD	2022-06-30 10-Q USD	2022-03-31 10-Q USD	2021-12-31 10-K USD	2021-09-30 10-Q USD	2021-06-30 10-Q USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-170,627,000	-4,957,000	-4,851,000	-5,206,000	-7,274,000	-8,274,000	-7,823,000	-7,787,000	-8,730,000	-8,142,000	-7,737,000	-10,177,000	-11,008,000	-13,048,000	-13,941,000	-10,712,000	-12,487,000	-9,413,000	-10,316,000	-9,784,000
Net Income	-170,236,000	-4,716,000	-4,569,000	-4,936,000	-6,864,000	-7,770,000	-7,253,000	-7,142,000	-7,992,000	-7,414,000	-7,124,000	-9,386,000	-10,177,000	-12,232,000	-13,416,000	-10,535,000	-12,405,000	-9,366,000	-9,685,000	-9,771,000
Cash From Operations	-10,733,000	-3,864,000	-3,586,000	-5,909,000	-7,094,000	-5,792,000	-5,470,000	-5,792,000	-7,616,000	-6,163,000	-4,661,000	-9,463,000	-11,736,000	-9,574,000	-6,803,000	-11,899,000	-10,750,000	-7,868,000	-5,577,000	-6,047,000
Capex	-6,000	0	0	-16,000	0	0	0	-109,000	-37,000	0	0	-29,000	-151,000	0	-250,000	-52,000	-19,000	-535,000	-388,000	-616,000
Free Cash Flow	-10,739,000	-3,864,000	-3,586,000	-5,925,000	-7,094,000	-5,792,000	-5,470,000	-5,901,000	-7,653,000	-6,163,000	-4,661,000	-9,492,000	-11,887,000	-9,574,000	-7,053,000	-11,951,000	-10,769,000	-8,403,000	-5,965,000	-6,663,000
Cash And Equivalents	152,325,000	8,668,000	10,562,000	12,557,000	9,877,000	9,994,000	19,131,000	11,891,000	10,956,000	13,011,000	11,343,000	10,226,000	8,109,000	17,795,000	11,450,000	9,899,000	8,721,000	7,159,000	9,533,000	15,599,000
Total Current Assets	204,232,000	21,507,000	25,785,000	29,572,000	35,682,000	41,929,000	48,098,000	53,944,000	60,234,000	67,250,000	73,836,000	81,069,000	98,608,000	108,589,000	118,482,000	127,491,000	138,977,000	148,542,000	158,162,000	165,613,000
Total Liabilities	14,191,000	4,310,000	4,582,000	4,469,000	6,286,000	6,975,000	7,475,000	7,607,000	8,221,000	9,479,000	10,658,000	10,379,000	13,083,000	14,968,000	14,817,000	12,120,000	14,730,000	6,712,000	6,041,000	4,599,000
Shares Outstanding	1,340,333	1,261,685	1,261,290	1,261,290	25,208,068	25,180,583	25,151,379	25,124,333	25,073,958	25,030,188	24,996,517	26,583,819	30,971,341	30,764,160	30,720,921	30,720,921	30,682,813	30,609,029	30,588,495	30,588,495
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	1,295,052	1,260,772	1,261,290	1,260,867	25,192,363	25,166,523	25,147,999	25,104,439	25,049,111	25,015,302	25,514,115	30,507,018	30,866,087	30,742,226	30,720,291	30,701,758	30,647,679	30,600,750	30,588,495	30,588,495
Weighted Avg Shares Basic	1,295,052	1,260,772	1,261,290	1,260,867	25,192,363	25,166,523	25,147,999	25,104,439	25,049,111	25,015,302	25,514,115	30,507,018	30,866,087	30,742,226	30,720,291	30,701,758	30,647,679	30,600,750	30,588,495	30,588,495
Net Share Count Change (Normalized)	6.2%	Insufficient evidence	Insufficient evidence	Insufficient evidence	0.1%	0.1%	0.1%	0.2%	0.2%	0.1%	-6.0%	-14.2%	0.7%	0.1%	0.0%	0.1%	0.2%	0.1%	0.0%	Insufficient evidence
Ownership Claim Change (Normalized)	-5.9%	Insufficient evidence	Insufficient evidence	Insufficient evidence	-0.1%	-0.1%	-0.1%	-0.2%	-0.2%	-0.1%	6.4%	16.5%	-0.7%	-0.1%	0.0%	-0.1%	-0.2%	-0.1%	0.0%	Insufficient evidence

Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input	Value	Source concept	Filing period	Confidence	Provenance
Current Assets	204,232,000USD	us-gaap:AssetsCurrent	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json
Total Liabilities	14,191,000USD	us-gaap:Liabilities	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json
Cash	152,325,000USD	us-gaap:CashAndCashEquivalentsAtCarryingValue	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json
Shares Outstanding	1,340,333	us-gaap:CommonStockSharesOutstanding	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json Data Vault \| sec/companyfacts/cik=0001829802/companyfacts.json
NCAV	190,041,000USD	derived	2026-03-31	n/a	company-evidence-v1 \| total_current_assets - total_liabilities
NCAV per share	141.79USD	derived	2026-03-31	n/a	company-evidence-v1 \| NCAV / shares_outstanding
Internal NCAV Discount	83.6%	derived	2026-03-31	n/a	gnni_publication_pack \| internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source: Data Vault
Data Vault Root: Local evidence | The Data Vault
CIK: 0001829802
Company ID: n/a
Selected Annual Source: Data Vault | sec/companyfacts/cik=0001829802/companyfacts.json
Selected Quarterly Source: Data Vault | sec/companyfacts/cik=0001829802/companyfacts.json
Statement Extractor: companyfacts-screener-v1
View Extractor: companyfacts-screener-v1
Source Accession Count: 21
Imported At: 2026-08-02T05:41:46+00:00
Rendered At: 2026-08-16T03:30:00+00:00

Run Audit

Mary Run: 062cd84c6cec4533b9bb580392e1f3bf
Mary As Of: 2026-08-07
Accession: 0001193125-26-225333
CIK: 0001829802
Mary Filing Date: 2026-05-15
Filing Currency: USD
Internal Discount: 83.6%
Source State: Verified
Market Context: Not Displayed
Market Policy: internal_only_not_redistributed
Share Trend: Not Evaluated
Dilution: Needs Review

mary_run=062cd84c6cec4533b9bb580392e1f3bf; mary_as_of=2026-08-07; mary_filing_date=2026-05-15; mary_accession=0001193125-26-225333; mary_cik=0001829802; gnni_supporting_filing_date=2026-05-15; internal_discount=0.835668; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive